|
| |
| | | | 1 | | | DO1.PCCNTR.1194442 ContractData Container |
| | | 1.1 | | | | | | | | | | 15,784,592.00 | 0.00 | 0.00 | 0.00 | 15,640,232.00 | 15,784,592.00 |
|
| | | | | | | 13 | | 2.3.4.1.01 | BEVACIZUMAB 100 MG, INY. (AVASTIN) | 30 | UD | 28,690 | 28,690 | 860,700.00 | | 0.00 | | | 0.00 | | 0.00 | 860,700.00 | 860,700.00 | |
|
| | | | | | | 14 | | 2.3.4.1.01 | BEVACIZUMAB 400 MG, INY. (AVASTIN) | 20 | UD | 107,540 | 114,758 | 2,295,160.00 | | 0.00 | | | 0.00 | | 0.00 | 2,150,800.00 | 2,295,160.00 | |
|
| | | | | | | 15 | | 2.3.4.1.01 | CAPECITABINA 500 MG, TAB. (XELODA) | 12,000 | UD | 180 | 180 | 2,160,000.00 | | 0.00 | | | 0.00 | | 0.00 | 2,160,000.00 | 2,160,000.00 | |
|
| | | | | | | 16 | | 2.3.4.1.01 | CETUXIMAB 5 MG, /20 ML AMPOLLA (ERBITUX) | 60 | UD | 30,215 | 30,215 | 1,812,900.00 | | 0.00 | | | 0.00 | | 0.00 | 1,812,900.00 | 1,812,900.00 | |
|
| | | | | | | 17 | | 2.3.4.1.01 | PERTUZUMAB 420 MG, (PERJETA) | 6 | UD | 246,452 | 246,452 | 1,478,712.00 | | 0.00 | | | 0.00 | | 0.00 | 1,478,712.00 | 1,478,712.00 | |
|
| | | | | | | 18 | | 2.3.4.1.01 | RITUXIMAB 1,400 MG, /11.7ML INY (MABTHERA) | 12 | UD | 78,400 | 78,400 | 940,800.00 | | 0.00 | | | 0.00 | | 0.00 | 940,800.00 | 940,800.00 | |
|
| | | | | | | 19 | | 2.3.4.1.01 | RITUXIMAB 500 MG, INY. (MABTHERA) | 15 | UD | 67,200 | 67,200 | 1,008,000.00 | | 0.00 | | | 0.00 | | 0.00 | 1,008,000.00 | 1,008,000.00 | |
|
| | | | | | | 20 | | 2.3.4.1.01 | TRASTUZUMAB 600 MG, / 5 ML VIAL (HERCEPTIN) | 40 | UD | 107,908 | 107,908 | 4,316,320.00 | | 0.00 | | | 0.00 | | 0.00 | 4,316,320.00 | 4,316,320.00 | |
|
| | | | | | | 21 | | 2.3.4.1.01 | ERITROPOYETINA 30,000 U.I.INY | 120 | UD | 7,600 | 7,600 | 912,000.00 | | 0.00 | | | 0.00 | | 0.00 | 912,000.00 | 912,000.00 | |
|
|
| | | |
| | | |
|